Nexstim NBT system’s shorter protocol receives FDA clearance

MDD is a recurrent chronic disorder with significant unmet clinical need. Credit: Małgorzata Tomczak from Pixabay.



  • Nexstim NBT system’s shorter protocol gets FDA nod